RELMADA THERAPEUTICS, INC. Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
RELMADA THERAPEUTICS, INC. (RLMD) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $19.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-19.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2024-03-19
- RELMADA THERAPEUTICS, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2023 was $19.00K, a 171.43% increase from fiscal 2022.
- RELMADA THERAPEUTICS, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2022 was $7.00K.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month |
|---|---|
| 2023-12-31 | $19.00K 10-K · filed 2024-03-19 |
| 2022-12-31 | $7.00K 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |